evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract,articles/12/pmid,articles/12/title,articles/12/journal,articles/12/pubDate,articles/12/volume,articles/12/issue,articles/12/pages,articles/12/authors,articles/12/elocationId,articles/12/link,articles/12/reference,articles/12/abstract,articles/13/pmid,articles/13/title,articles/13/journal,articles/13/pubDate,articles/13/volume,articles/13/issue,articles/13/pages,articles/13/authors,articles/13/elocationId,articles/13/link,articles/13/reference,articles/13/abstract,articles/14/pmid,articles/14/title,articles/14/journal,articles/14/pubDate,articles/14/volume,articles/14/issue,articles/14/pages,articles/14/authors,articles/14/elocationId,articles/14/link,articles/14/reference,articles/14/abstract,articles/15/pmid,articles/15/title,articles/15/journal,articles/15/pubDate,articles/15/volume,articles/15/issue,articles/15/pages,articles/15/authors,articles/15/elocationId,articles/15/link,articles/15/reference,articles/15/abstract,articles/16/pmid,articles/16/title,articles/16/journal,articles/16/pubDate,articles/16/volume,articles/16/issue,articles/16/pages,articles/16/authors,articles/16/elocationId,articles/16/link,articles/16/reference,articles/16/abstract,articles/17/pmid,articles/17/title,articles/17/journal,articles/17/pubDate,articles/17/volume,articles/17/issue,articles/17/pages,articles/17/authors,articles/17/elocationId,articles/17/link,articles/17/reference,articles/17/abstract,articles/18/pmid,articles/18/title,articles/18/journal,articles/18/pubDate,articles/18/volume,articles/18/issue,articles/18/pages,articles/18/authors,articles/18/elocationId,articles/18/link,articles/18/reference,articles/18/abstract,articles/19/pmid,articles/19/title,articles/19/journal,articles/19/pubDate,articles/19/volume,articles/19/issue,articles/19/pages,articles/19/authors,articles/19/elocationId,articles/19/link,articles/19/reference,articles/19/abstract,articles/20/pmid,articles/20/title,articles/20/journal,articles/20/pubDate,articles/20/volume,articles/20/issue,articles/20/pages,articles/20/authors,articles/20/elocationId,articles/20/link,articles/20/reference,articles/20/abstract
17795,GENE_BACKGROUND,,"The XPO1 (Exportin 1) encodes a protein that mediates nuclear export of proteins and RNA (PMID: 9323132, 10786834). XPO1 recognizes proteins containing a nuclear export signal (NES) and leads to their export from the nucleus to the cytoplasm. XPO1 has been reported to be involved in ribosome biogenesis by exporting the 60S ribosome subunit through binding to NMD3 (PMID: 26048327, 12724356). In the context of cancer, XPO1 has oncogenic properties. This has been mostly attributed to the fact that proteins exported by XPO1 include important tumor suppressors (eg. APC, TP53, SMARCB1 etc.)(PMID: 12070164, 11782423, 17891139, 20803015). High nuclear XPO1 expression is associated with adverse prognosis in various tumor entities (PMID: 18306389, 19082467, 20003838) and XPO1 mutations have been reported in some cases of chronic lymphatic leukemia (CLL) as well as diffuse large B-cell lymphoma (DLBCL) (PMID: 21642962, 26608593). XPO1 translocations have been reported in T-ALL (PMID: 25377562). Small molecule inhibitors of nuclear export (SINEs) have been developed and tested in preclinical studies in various tumor types and show promising therapeutic efficacy (PMID: 23034282, 23373539, 23970380, 25057921, 24431073, 23588715, 25366336).",,2017-03-28,,7514,XPO1,exportin 1,False,ENST00000401558,NM_003400.3,emb,exp1,CRM1,False,24431073,XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.,Molecular cancer therapeutics,2018-03-01T20:14:00,13,3,675-86,Cheng Y et al,doi: 10.1158/1535-7163.MCT-13-0416,,0001-03-01,,21642962,Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.,Nature,2018-06-05T20:11:00,475,7354,101-5,Puente XS et al,doi: 10.1038/nature10113,,0001-06-05,,10786834,"PHAX, a mediator of U snRNA nuclear export whose activity is regulated by phosphorylation.",Cell,2018-04-14T20:00:00,101,2,187-98,Ohno M et al,,,0001-04-14,,12724356,Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway.,Journal of cell science,2018-06-15T20:03:00,116,Pt 12,2409-19,Thomas F et al,,,0001-06-15,,23970380,Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.,Blood,2018-10-24T20:13:00,122,17,3034-44,Walker CJ et al,doi: 10.1182/blood-2013-04-495374,,0001-10-24,,26048327,"Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.",Pharmacology &amp; therapeutics,2018-09-01T20:15:00,153,,25-35,Ishizawa J et al,doi: 10.1016/j.pharmthera.2015.06.001,,0001-09-01,,20003838,Prognostic value of CRM1 in pancreas cancer.,Clinical and investigative medicine. Medecine clinique et experimentale,2017-12-01T20:09:00,32,6,E315,Huang WY et al,,,0001-12-01,,23034282,Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia.,Blood,2017-11-29T20:12:00,120,23,4621-34,Lapalombella R et al,doi: 10.1182/blood-2012-05-429506,,0001-11-29,,19082467,The expression of CRM1 is associated with prognosis in human osteosarcoma.,Oncology reports,2018-01-01T20:09:00,21,True,229-35,Yao Y et al,,,0001-01-01,,17891139,Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation.,Nature cell biology,2018-10-01T20:07:00,9,10,1175-83,Kanai M et al,,,0001-10-01,,25377562,Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL.,Blood,2018-11-06T20:14:00,124,19,3023-5,Bond J et al,doi: 10.1182/blood-2014-04-567636,,0001-11-06,,23373539,KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.,British journal of haematology,2018-04-01T20:13:00,161,True,117-27,Etchin J et al,doi: 10.1111/bjh.12231,,0001-04-01,,20803015,p53-Dependent anticancer effects of leptomycin B on lung adenocarcinoma.,Cancer chemotherapy and pharmacology,2018-06-01T20:11:00,67,6,1369-80,Shao C et al,doi: 10.1007/s00280-010-1434-6,,0001-06-01,,23588715,CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.,Leukemia,2018-01-01T20:14:00,28,True,155-65,Tai YT et al,doi: 10.1038/leu.2013.115,,0001-01-01,,26608593,Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.,"Genes, chromosomes &amp; cancer",2018-03-01T20:16:00,55,3,251-67,Mareschal S et al,doi: 10.1002/gcc.22328,,0001-03-01,,25366336,Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma.,Neuro-oncology,2018-05-01T20:15:00,17,5,697-707,Green AL et al,doi: 10.1093/neuonc/nou303,,2018-05-01T07:07:00,,9323132,Exportin 1 (Crm1p) is an essential nuclear export factor.,Cell,0001-09-19,90,6,1041-50,Stade K et al,,,0001-09-19,,12070164,The coiled coil region (amino acids 129-250) of the tumor suppressor protein adenomatous polyposis coli (APC). Its structure and its interaction with chromosome maintenance region 1 (Crm-1).,The Journal of biological chemistry,2018-08-30T20:02:00,277,35,32332-8,Tickenbrock L et al,,,0001-08-30,,11782423,A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis.,The EMBO journal,2018-01-15T20:02:00,21,2001-01-02,31-42,Craig E et al,,,2002-01-02,,18306389,Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.,Cancer,2018-04-15T20:08:00,112,8,1733-43,Noske A et al,doi: 10.1002/cncr.23354,,0001-04-15,,25057921,"Novel small molecule XPO1/CRM1 inhibitors induce nuclear accumulation of TP53, phosphorylated MAPK and apoptosis in human melanoma cells.",PloS one,2014,9,7,e102983,Yang J et al,doi: 10.1371/journal.pone.0102983,,Yang J et al. PloS one. 2014;9(7)e102983.,
17794,GENE_SUMMARY,,XPO1 encodes a protein that mediates nuclear export of proteins and RNA. It acts as an oncogene in various tumor types by exporting tumor suppressors from the nucleus to the cytoplasm of tumor cells.,,2017-03-28,,7514,XPO1,exportin 1,False,ENST00000401558,NM_003400.3,emb,exp1,CRM1,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
